Bloomberg on MSN6mon
Novartis Raises 2024 Profit Forecast on Demand for New Blockbuster Drugs
The forecast upgrade was widely expected, Naresh Chouhan, a London-based analyst with Intron Health, said in a note to ...
Novartis agrees $3bn deal to buy heart drug biotech from Blackstone
Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...